Testing the Potential Metabolic Effect of the Human Gut Bacterial Peptide, RUCILP, in Healthy Men

Clinical trial NCT06923839 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06923839
Sponsor: Oluf Pedersen
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Male Adults

Start date: 2025-07-28
Primary completion: 2025-08-27
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.